Commission Directive 2009/77/EC [Commission Directive 2009/77/EC of 1 July 2009 amending Council Directive 91/414/EEC to include chlorsulfuron, cyromazine, dimethachlor, etofenprox, lufenuron, penconazole, tri-allate and triflusulfuron as active substances (OJ L 172, 2.7.2009, p. 23, ELI: http://data.europa.eu/eli/dir/2009/77/oj).] included dimethachlor and penconazole in Annex I to Directive 91/414/EEC as active substances until 31 December 2019 and they were subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approvals of dimethachlor and penconazole were extended four times, most recently by Commission Implementing Regulation (EU) 2023/2592 [Commission Implementing Regulation (EU) 2023/2592 of 21 November 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-naphthylacetamide, 1-naphthylacetic acid, 2-phenylphenol (incl. its salts such as sodium salt), 8-hydroxyquinoline, amidosulfuron, bifenox, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fluazifop P, lenacil, napropamide, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, spiroxamine, sulphur, tetraconazole and tri-allate (OJ L, 2023/2592, 22.11.2023, ELI: http://data.europa.eu/eli/reg_impl/2023/2592/oj).], both until 15 October 2026.
Recital 12, Regulation (EU) 2026/1826
In forcesince 28 Jul 2026
Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulati…Law
- celex=31991L0414
- celex=32009L0077
- num:eu=2009/77